latest news releases from the newsroom
Immunomedics Announces Combination Therapy of Milatuzumab and Rituximab is Active in Mantle Cell Lymphoma Model
SAN FRANCISCO, Dec. 9, 2008 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that combining milatuzumab with rituximab prolonged survival of animals injected with human mantle cell lymphoma cells. Results from this preclinical study were reported in an oral presentation at the 50th annual meeting of ASH by Dr. Lapo Alinari of the Comprehensive Cancer Center, The Ohio State University, Columbus, OH.
Aceto Appoints President and Executive Vice President
LAKE SUCCESS, N.Y., Dec. 9, 2008 (GLOBE NEWSWIRE) -- Aceto Corporation (Nasdaq:ACET), a global leader in the sourcing, quality assurance, regulatory support, marketing and distribution of chemically derived pharmaceuticals, biopharmaceuticals, specialty chemicals and crop protection products, today announced two promotions. Effective January 1, 2009, Vincent Miata, Senior Vice President responsible for the Company's Chemicals & Colorants business, has been promoted to President and Frank DeBenedittis, Senior Vice President of the Company's Health Sciences business, has been promoted to Executive Vice President. Frank will also assume the additional responsibility of the newly created position of Director of Global Pharmaceutical Strategy.